We’ve all been told that alcohol is not good for health, especially for the liver. New York-based Indian researcher and son of the founder of Granules India Ltd., Harsha Chigurupati has developed a compound that will help protect against liver and DNA damage caused by consuming alcohol - called NTX - 'no-tox.'
Granules India Ltd. is one of the world’s largest manufacturers of off-patent drugs. Chigurupati saw the damage that pain relievers can do to the liver. He watched as scientists at Granules sought to lessen those effects using additives. In 2002, he left Hyderabad, India, for Boston University and, after a night of drinking, woke up with a headache and an idea, reported The Wall Street Journal.
After graduation, Chigurupati spent 12 years and $35 million to create the compound. During human trials, the technology has managed to reduce the negative effects of alcohol on the liver and DNA by 93%.
According to The Wall Street Journal report, NTX contains three basic ingredients, potassium sorbate, a food preservative and anti-oxidant, glycyrrhizin, an anti-inflammatory derived from the liquorice root, and mannitol, a diuretic that causes the body to lose water.Chigurupati claims NTX has following benefits:
• Helps maintain normal liver enzyme production and function
• Helps maintain normal liver functions
• Reduces the risk of alcohol-induced liver diseases, including fibrosis and cirrhosis
• Supports normal liver defenses and regenerative mechanisms
Human trials funded by Harsha Chigurupati for NTX began in 2013. The agency that regulates such claims in the US, the Alcohol and Tobacco ax and Trade Bureau (TTB), denied Chigurupati's petition even though his research showing that the key ingredients in NTX mitigate liver damage and oxidative stress was up to the required standards.While Chigurupati is currently battling with regulators, New Jersey-based spirits brand Bellion already sells NTX infused vodka in bars and restaurants in 11 states for around $30 a bottle. Chigurupati teamed up with Bellion, with the hope of disrupting the liquor industry with a new alcohol category labelled 'functional spirits,' which he trademarked. Chigurupati aims to roll out another 16 spirits using NTX over the next three years, hoping his long effort to develop NTX will remake the spirits landscape—or at least give drinks that will take less of a toll on your body.